Poststreptococcal Glomerulonephritis Questions & Answers

1. Balasubramanian R, Marks SD. Post-infectious glomerulonephritis. Paediatr Int Child Health. 2017 Sep 11. 1-8. [Medline].

2. Maness DL, Martin M, Mitchell G. Poststreptococcal Illness: Recognition and Management. Am Fam Physician. 2018 Apr 15. 97 (8):517-522. [Medline]. [Full Text].

3. Zegers RH, Weigl A, Steptoe A. The death of Wolfgang Amadeus Mozart: an epidemiologic perspective. Ann Intern Med. 2009 Aug 18. 151(4):274-8, W96-7. [Medline].

4. Rodriguez-Iturbe B, Musser JM. The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol. 2008 Oct. 19(10):1855-64. [Medline].

5. Ahn SY, Ingulli E. Acute poststreptococcal glomerulonephritis: an update. Curr Opin Pediatr. 2008 Apr. 20(2):157-62. [Medline].

6. Torres RSLA, Santos TZ, Bernardes AFL, Soares PA, Soares ACC, Dias RS. Outbreak of Glomerulonephritis Caused by Streptococcus zooepidemicus SzPHV5 Type in Monte Santo de Minas, Minas Gerais, Brazil. J Clin Microbiol. 2018 Oct. 56 (10):[Medline]. [Full Text].

7. Stamatiades EG, Tremblay ME, Bohm M, Crozet L, Bisht K, Kao D, et al. Immune Monitoring of Trans-endothelial Transport by Kidney-Resident Macrophages. Cell. 2016 Aug 11. 166 (4):991-1003. [Medline].

8. Batsford SR, Mezzano S, Mihatsch M, et al. Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH?. Kidney Int. 2005 Sep. 68(3):1120-9. [Medline].

9. Oda T, Yoshizawa N, Yamakami K, Sakurai Y, Takechi H, Yamamoto K, et al. The role of nephritis-associated plasmin receptor (NAPlr) in glomerulonephritis associated with streptococcal infection. J Biomed Biotechnol. 2012. 2012:417675. [Medline]. [Full Text].

10. Bakr A, Mahmoud LA, Al-Chenawi F, et al. HLA-DRB1* alleles in Egyptian children with post-streptococcal acute glomerulonephritis. Pediatr Nephrol. 2007 Mar. 22(3):376-9. [Medline].

11. Ilyas M, Tolaymat A. Changing epidemiology of acute post-streptococcal glomerulonephritis in Northeast Florida: a comparative study. Pediatr Nephrol. 2008 Jul. 23(7):1101-6. [Medline].

12. Jackson SJ, Steer AC, Campbell H. Systematic Review: Estimation of global burden of non-suppurative sequelae of upper respiratory tract infection: rheumatic fever and post-streptococcal glomerulonephritis. Trop Med Int Health. 2011 Jan. 16(1):2-11. [Medline].

13. Limm-Chan B, Musgrave J, Lau R, Ahn HJ, Nguyen L, Kurahara D. Incidence of Acute Post-Streptococcal Glomerulonephritis in Hawai'i and Factors Affecting Length of Hospitalization. Hawaii J Health Soc Welf. 2020 May 1. 79 (5):149-152. [Medline]. [Full Text].

14. Chaturvedi S, Boyd R, Krause V. Acute Post-Streptococcal Glomerulonephritis in the Northern Territory of Australia: A Review of Data from 2009 to 2016 and Comparison with the Literature. Am J Trop Med Hyg. 2018 Dec. 99 (6):1643-1648. [Medline]. [Full Text].

15. Rodriguez-Iturbe B, Musser JM. The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol. 2008 Oct. 19(10):1855-64. [Medline].

16. Hoy WE, White AV, Dowling A, Sharma SK, Bloomfield H, Tipiloura BT, et al. Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life. Kidney International. May 2012. 81(10):1026-32. [Medline].

17. Araki Y, Kawaguchi A, Sakakibara N, Nagaoka Y, Yamamura T, Horinouchi T, et al. Poststreptococcal acute glomerulonephritis can be a risk factor for accelerating kidney dysfunction in Alport syndrome: a case experience. CEN Case Rep. 2020 Nov. 9 (4):418-422. [Medline]. [Full Text].

18. VanDeVoorde RG 3rd. Acute poststreptococcal glomerulonephritis: the most common acute glomerulonephritis. Pediatr Rev. 2015 Jan. 36 (1):3-12; quiz 13. [Medline].

19. Kakajiwala A, Bhatti T, Kaplan BS, Ruebner RL, Copelovitch L. Post-streptococcal glomerulonephritis associated with atypical hemolytic uremic syndrome: to treat or not to treat with eculizumab?. Clin Kidney J. 2016 Feb. 9 (1):90-6. [Medline].

20. Mara-Koosham G, Stoltze K, Aday J, Rendon P. Pulmonary Renal Syndrome After Streptococcal Pharyngitis: A Case Report. J Investig Med High Impact Case Rep. 2016 Apr-Jun. 4 (2):2324709616646127. [Medline]. [Full Text].

21. Adikari M, Priyangika D, Marasingha I, Thamotheram S, Premawansa G. Post-streptococcal glomerulonephritis leading to posterior reversible encephalopathy syndrome: a case report. BMC Res Notes. 2014 Sep 13. 7:644. [Medline]. [Full Text].

22. Zaki SA, Shanbag P. Unusual presentation of poststreptococcal glomerulonephritis as posterior reversible encephalopathy syndrome. J Pediatr Neurosci. 2014 Jan. 9 (1):42-4. [Medline].

23. Ayoob RM, Schwaderer AL. Acute Kidney Injury and Atypical Features during Pediatric Poststreptococcal Glomerulonephritis. Int J Nephrol. 2016. 2016:5163065. [Medline]. [Full Text].

24. Parra G, Rodriguez-Iturbe B, Batsford S, et al. Antibody to streptococcal zymogen in the serum of patients with acute glomerulonephritis: a multicentric study. Kidney Int. 1998 Aug. 54(2):509-17. [Medline].

25. Glassock RJ, Alvarado A, Prosek J, Hebert C, Parikh S, Satoskar A, et al. Staphylococcus-related glomerulonephritis and poststreptococcal glomerulonephritis: why defining "post" is important in understanding and treating infection-related glomerulonephritis. Am J Kidney Dis. 2015 Jun. 65 (6):826-32. [Medline].

26. Nadasdy T, Hebert LA. Infection-related glomerulonephritis: understanding mechanisms. Semin Nephrol. 2011 Jul. 31 (4):369-75. [Medline].

27. Taskesen M, Taskesen T, Katar S, et al. Elevated plasma levels of N-terminal pro-brain natriuretic peptide in children with acute poststreptococcal glomerulonephritis. Tohoku J Exp Med. 2009 Apr. 217(4):295-8. [Medline]. [Full Text].

28. Wu SH, Liao PY, Yin PL, Zhang YM, Dong L. Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis. Am J Pathol. 2009 Jan. 174(1):115-22. [Medline]. [Full Text].

29. Sorger K, Gessler U, Hubner FK, et al. Subtypes of acute postinfectious glomerulonephritis. Synopsis of clinical and pathological features. Clin Nephrol. 1982 Mar. 17(3):114-28. [Medline].

Duvuru Geetha, MD, MRCP Assistant Professor of Medicine, Department of Renal Medicine, Bayview Medical Center, Johns Hopkins University School of Medicine

Duvuru Geetha, MD, MRCP is a member of the following medical societies: American College of Rheumatology, American Society of Nephrology

Disclosure: for: Consultant to ChemoCentryx and Consultant to Kyowa Hakko Kirin and Consultant to Aurynia.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Ajay K Singh, MB, MRCP, MBA Associate Professor of Medicine, Harvard Medical School; Director of Dialysis, Renal Division, Brigham and Women's Hospital; Director, Brigham/Falkner Dialysis Unit, Faulkner Hospital

Disclosure: Nothing to disclose.

Vecihi Batuman, MD, FASN Huberwald Professor of Medicine, Section of Nephrology-Hypertension, Interim Chair, Deming Department of Medicine, Tulane University School of Medicine

Vecihi Batuman, MD, FASN is a member of the following medical societies: American College of Physicians, American Society of Hypertension, American Society of Nephrology, International Society of Nephrology, Southern Society for Clinical Investigation

Disclosure: Nothing to disclose.

Chike Magnus Nzerue, MD, FACP Professor of Medicine, Associate Dean for Clinical Affairs, Meharry Medical College

Chike Magnus Nzerue, MD, FACP is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Society of Nephrology, National Kidney Foundation

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article